are prescription-only tablets used to treat advanced kidney cancer, hormone receptor-positive breast cancer, and neuroendocrine tumors. They are also prescribed for preventing organ transplant rejection. As an mTOR inhibitor, Everolimus helps slow abnormal cell growth and reduces immune responses for better transplant outcomes.
Everolimus Tablets 10 mg offer targeted treatment for advanced cancers and immunosuppressive therapy to prevent organ rejection in transplant patients. This prescription-only medicine belongs to the class of mTOR inhibitors, which interfere with cellular activity involved in growth, replication, and immune function.
Primarily used in oncology and transplant care, Everolimus is prescribed by specialists to manage several life-threatening conditions. The 10 mg dosage strength is generally recommended for adults under detailed treatment plans and monitoring.
You must be logged in to post a review.